Nektar Therapeutics —— 现金流量表 (NASDAQ:NKTR) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -313.29 M-412.66 M-304.01 M-192.61 M-175.71 M-208.51 M -208.51 M 投资活动产生的现金 496.21 M202.78 M365.83 M139.56 M142.57 M-1.2 M -1.2 M 融资活动产生的现金 -80.35 M36.24 M1.51 M30 K42.12 M180.57 M 180.57 M 自由现金流 -320.55 M-427.65 M-309.68 M-193.47 M-177.18 M-208.68 M -208.68 M

新闻

Nektar (NKTR) Moves 18.3% Higher: Will This Strength Last?

Nektar Therapeutics (NKTR) Discusses 52-Week Topline Results From REZOLVE-AA Phase 2b Extension in Severe Alopecia Areata - Slideshow (NASDAQ:NKTR) 2026-04-20

Nektar Therapeutics (NKTR) Discusses 52-Week Topline Results From REZOLVE-AA Phase 2b Extension in Severe Alopecia Areata Transcript

Nektar Therapeutics Adds To Its 129% Two-Month Run With Alopecia News

Market Feels Weak, But Stocks Tell Stories

Stay Invested In U.S. Stocks, Don't Panic Sell, Also Buy Gold

TD Cowen首次覆盖Nektar Therapeutics股票并给予买入评级

Nektar Therapeutics stock initiated with buy rating at TD Cowen

Company News for Mar 16, 2026

Oppenheimer上调Nektar Therapeutics目标价至140美元

Oppenheimer raises Nektar Therapeutics price target to $140

Nektar Therapeutics股价触及52周高点76.3美元